CIK 0002029039 · Non-accelerated filer<br>Emerging growth company
Nasus Pharma Ltd
Sign in to watch- Ticker
- NSRX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- EIN
- 516022712
- Phone
- 972 54-255-3956
- Business address
- 29 HARAKEVET ST, TEL AVIV - YAFO, Israel, 6618003
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | O'Grady Brendan P. Chief Executive Officer | Grant or award · Share options (right to buy) | +210,000 | 210,000 | ||
| 2026-06-17 | Teleman Dan Benjamin Chief Executive Officer | Purchase | +6,550 | $3.10 | $20K | 163,541 |
| 2026-04-22 | Teleman Dan Benjamin Chief Executive Officer | Purchase | +2,900 | $3.76 | $11K | 156,991 |
| 2026-03-31 | Teleman Dan Benjamin Chief Executive Officer | Purchase | +15,000 | $2.04 | $31K | 21,246 |
Page 1 of 1 · 4 trades